American Century Companies’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
ACA
American Century Companies's CYTK Position: Q2 2026 in Review
American Century Companies increased its Cytokinetics (CYTK) stake by 17% in Q2 2026, buying an estimated $5.35M and bringing the position to 518,398 shares worth $44.2M. The position accounts for 0.02% of the portfolio, ranked #906.
American Century Companies first reported a position in CYTK in Q3 2013 and has held it in 24 quarters since. The position peaked at $94.2M in Q1 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- American Century Companies held 518,398 shares of Cytokinetics worth $44.2M as of Q2 2026.
- American Century Companies bought 74,441 Cytokinetics shares in Q2 2026, an estimated $5.35M.
- Cytokinetics made up 0.02% of American Century Companies's portfolio in Q2 2026, its #906 holding.
- American Century Companies first reported a position in Cytokinetics in Q3 2013 and has held it in 24 quarters since.
- American Century Companies's Cytokinetics position peaked at $94.2M in Q1 2023.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.